Core Viewpoint - UBS reports that Angelalign Technology (06699) has exceeded expectations in its interim performance, with significant growth in revenue and net profit [1] Financial Performance - Revenue for the first half reached $161 million, representing a year-on-year increase of 33.1%, surpassing UBS's expectations [1] - Net profit stood at $14.2 million, showing a remarkable year-on-year growth of 584%, aligning with expectations [1] - Adjusted net profit was $19.5 million, reflecting an 85% year-on-year increase [1] - Total case volume increased by 47.7% year-on-year, indicating strong operational growth [1] - Gross margin remained stable at 62.4% [1] Analyst Recommendations - UBS raised the target price from HKD 82 to HKD 91 [1] - The brokerage changed the earnings per share estimate from RMB to USD [1] - UBS reiterated a "Buy" rating for the stock [1]
瑞银：升时代天使目标价至91港元 中期业绩胜预期